Yulin Wu

Yulin Wu, ACRP-CP, is a seasoned professional in clinical operations with extensive experience in the biopharmaceutical industry. Currently serving as the Sr Director of Clinical Operations at Nuvation Bio since July 2024, Yulin Wu transitioned to this role following the acquisition of AnHeart Therapeutics, where Yulin Wu worked as Clinical Operations Director from October 2022 to July 2024. Prior to that, Yulin Wu held Clinical Operations Director positions at EpimAb Biotherapeutics, Inc., and served as Senior Project Manager at Clinipace. Previous roles include Associate Director of Project Management/Therapeutic Strategy Liaison at WuXi Clinical and various positions at Syneos Health, including Project Manager and Project Specialist in Oncology and Hematology. Yulin Wu began a career in research, working at GSK and AMRI, and holds a Master's Degree in Organic Chemistry from The University of Akron and a Bachelor's Degree in Applied Chemistry from Shanghai Jiao Tong University.